QUIDELORTHO CORP Amortization of Debt Discount (Premium)
QUIDELORTHO CORP (QDEL) reported Amortization of Debt Discount (Premium) of $1.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-07
- QUIDELORTHO CORP amortization of debt discount (premium) for the quarter ending 2026-06-28 was $1.00M.
- QUIDELORTHO CORP amortization of debt discount (premium) for the quarter ending 2026-03-29 was $1.00M.
- QUIDELORTHO CORP amortization of debt discount (premium) for the quarter ending 2025-12-28 was $700.00K.
- QUIDELORTHO CORP amortization of debt discount (premium) for the quarter ending 2025-09-28 was $400.00K.
- QUIDELORTHO CORP amortization of debt discount (premium) for fiscal 2025 was $1.10M.
- QUIDELORTHO CORP amortization of debt discount (premium) for fiscal 2024 was $0.00.
- QUIDELORTHO CORP amortization of debt discount (premium) for fiscal 2023 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-28 | $1.00M 10-Q · filed 2026-08-07 | $2.00M 10-Q · filed 2026-08-07 | $2.70M derived: sum of 3 quarters · filed 2026-08-07 | $3.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $1.00M 10-Q · filed 2026-05-06 | $1.70M derived: sum of 2 quarters · filed 2026-05-06 | $2.10M derived: sum of 3 quarters · filed 2026-05-06 | $2.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.10M derived: sum of 2 quarters · filed 2026-02-19 | $1.10M derived: sum of 3 quarters · filed 2026-08-07 | $1.10M 10-K · filed 2026-02-19 |
| 2025-09-28 | $400.00K 10-Q · filed 2025-11-06 | $400.00K derived: sum of 2 quarters · filed 2026-08-07 | $400.00K 10-Q · filed 2025-11-06 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 | |
| 2024-09-29 | $0.00 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |